covid
Buscar en
Angiología
Toda la web
Inicio Angiología Angioplastia frente a angioplastia más stent en el sector infrainguinal. Result...
Información de la revista
Vol. 56. Núm. 4.
Páginas 367-379 (enero 2004)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 56. Núm. 4.
Páginas 367-379 (enero 2004)
Acceso a texto completo
Angioplastia frente a angioplastia más stent en el sector infrainguinal. Resultados de 100 procedimientos endovasculares consecutivos
Angioplasty versus angioplasty plus stent-graft in the infrainguinal segment. results of 100 consecutive endovascular procedures
Angioplastia versus angioplastia com prótese no sector infra-inguinal. resultados de 100 procedimentos endovasculares consecutivos
Visitas
2213
F. Utrilla-Fernández
Autor para correspondencia
futrillaf@yahoo.es

Correspondencia: Servicio de Angiología y Cirugía Vascular. Hospital Universitario de Getafe. Ctra. Toledo, km 12,5. E-28905 Getafe (Madrid).
, F. Acín-García, J.R. March-García, A. Fernández-Heredero, A. López-Quintana, J. de Haro-Miralles
Servicio de Angiología y Cirugía Vascular. Hospital Universitario de Getafe. Getafe, Madrid, España.
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Resumen
Objetivo

Analizar los resultados de los 100 primeros procedimientos endovasculares infrainguinales realizados en un servicio de Angiología y Cirugía Vascular.

Pacientes y métodos

Análisis retrospectivo de 100 procedimientos endovasculares infrain-guinales, 46 angioplastia transluminal perxcutánea (ATP) simple y 54 ATP más stent, en 96 pacientes (100 extremidades) con 136 lesiones femoropoplíteas. Todas las indicaciones de implantación de stent fueron por resultado incompleto de la ATP simple. La indicación clínica fue: claudicación incapacitante, 19%; isquemia critica, 81%. El sector infrainguinal tratado fue: femoral superficial: 73; poplítea: 63. La longitud lesional fue: <3cm, en 52 procedimientos; entre 3-8cm, 83 procedimientos, y >8cm, en un caso. Analizamos resultados a corto plazo según estándares y en el seguimiento mediante análisis actuarial.

Resultados

La permeabilidad de la serie general a 21 meses fue del 61,5% (59,2% ATP simple frente a 68,6% ATP stent). En pacientes con isquemia critica la permeabilidad a 15 meses fue del 61,1% (56,7 frente a 69,6%). La tasa de salvación de extremidad a 21 meses fue del 83% (82,2 frente a 88,9%) y supervivencia del 92,7% (91,9 frente a 94,1%). En cada comparación las diferencias no fueron significativas. Tampoco hubo diferencias en el análisis de la ATP simple frente a ATP-stent en función de los vasos de salida distal, lesiones complejas (TASC C-D) ni oclusiones. Hubo diferencia significativa en las lesiones más leves (TASC A-B), (65,3 frente a 71,2%) y en las estenosis (61,9 frente a 85,7%).

Conclusiones

Los procedimientos endovasculares en el sector femoropoplíteo muestran buenos resultados a corto y medio plazo con una tendencia superior para la ATPstent, aunque esta diferencia sólo es significativa en presencia de estenosis o lesiones del tipo A-B (TASC).

Palabras clave:
Angioplastia
ATP
Endovascular
Femoropoplíteo
Isquemia crítica
Stent
Summary
Aim

Our aim was to analyse the results of the first 100 infrainguinal endovascular procedures performed in an Angiology and Vascular Surgery service.

Patients and methods

We conducted a retrospective analysis of 100 infrainguinal endovascular procedures, 46 simple percutaneous transluminal angioplasties (PTA) and 54 PTA plus stent, in 96 patients (100 limbs) with 136 femoral-popliteal lesions. All the indications for stent grafting were derived from the incomplete results obtained in the simple PTA. The clinical indications were: disabling claudication, 19%; critical ischemia, 81%. The infrainguinal segment treated was: superficial femoral: 73; popliteal: 63. Length of lesion was: <3cm, in 52 procedures; between 3-8cm, 83 procedures, and >8cm, in one case. We analyse short-term results according to standards and in the follow-up using actuarial analysis.

Results

Patency of the general series at 21 months was 61.5% (59.2% simple PTA versus 68.6% PTA-stent). In patients with critical ischemia patency at 15 months was 61.1% (56.7 versus 69.6%). Limb salvage rate at 21 months was 83% (82.2 versus 88.9%) and survival was 92.7% (91.9 versus 94.1%). In each comparison the differences were not significant. No differences were found in the analysis of simple PTA versus PTA-stent in terms of the distal outlet vessels, complex lesions (TASC C-D) or occlusions. Significant differences were found in the slightest lesions (TASC A-B), (65.3 versus 71.2%) and in stenoses (61.9 versus 85.7%).

Conclusions

Endovascular procedures carried out in the femoral-popliteal segment offer good short and medium-term results with a higher tendency for the PTA-stent, although this difference is only significant in the presence of stenoses or A-B type (TASC) lesions.

Key words:
Angioplasty.
Critical ischemia
Endovascular
Femoral-popliteal
PTA
Stent
Resumo
Objectivo

Analisar os resultados dos 100 primeiros procedimentos endovasculares infra-inguinais realizados num serviço de Angiologia e Cirurgia Vascular.

Doentes e métodos

Análise retrospectiva de 100 procedimentos endovasculares infra-inguinais, 46 angioplastias transluminais percutâneas (ATP) simples e 54 ATP com prótese, em 96 doentes (100 membros) com 136 lesões fémoro-popliteias. Todas as indicações de implantação de prótese foram por resultado incompleto da ATP simples. A indicação clínica foi: claudicação incapacitante, 19%; isquemia crítica, 81%, O sector infra-inguinal tratado foi: femoral superficial, 73; popliteia, 63. O comprimento da lesão foi: <3cm em 52 procedimentos; entre 3-8cm, 83 procedimentos; e >8cm, num caso. Analisámos os resultados a curto prazo segundo padrões e no seguimento através de análise actuarial.

Resultados

A permeabilidade da série geral a 21 meses foi de 61,5% (59,2% ATP simples versus 68,6% ATP com prótese). Em doentes com isquemia crítica, a permeabilidade a 15 meses foi de 61,1% (56,7 versus 69,6%). A taxa de salvamento do membro aos 21 meses foi de 83% (82,2 versus 88,9%) e a sobrevivência de 92,7% (91,9 versus 94,1%). Em cada comparação as diferenças não foram significativas. Tão pouco se observaram diferenças na análise da ATP simples versus ATP com prótese em função dos vasos de saída distal, das lesões complexas (TASC C-D) nem nas oclusões. Houve diferença significativa nas lesões mais ligeiras (TASC A-B), (65,3 versus 71,2%) e nas estenoses (61,9 versus 85,7%).

Conclusões

Os procedimentos endovasculares no sector fémoro-poplíteu revelam bons resultados a curto e médio prazo, com uma tendência superior para a ATP com prótese, embora esta diferença apenas seja significativa na presença de estenoses ou lesões do tipo A-B (TASC).

Palavras chave:
Angioplastia
ATP
Endovascular
Fémoro-poplíteu
Isquemia crítica
Prótese
El Texto completo está disponible en PDF
Bibliografía
[1.]
Grimm J., Müller-Hülsbeck S., Jahnke T., Hilbert C., Brossmann J., Heller M..
Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions.
J Vasc Interv Radiol, 12 (2001), pp. 935-941
[2.]
Newman A.B., Sutton-Tyrrell K., Vogt M.T., Kuller L.H..
Morbidity and mortality in hypertensive adults with low ankle/arm blood pressure index.
JAMA, 270 (1993), pp. 487-489
[3.]
Juergens J.L., Barker N.W., Hines E.A. Jr..
Arteriosclerosis obliterans: review of 520 cases with special reference to pathogenic and prognostic factors.
Circulation, 21 (1960), pp. 188-195
[4.]
Humphries A.W., De Wolf V.G., Young J.R..
Evaluation of the natural history and results of treatment in occlusive arteriosclerosis involving the lower extremity in 1850 patients.
Fundamentals of vascular grafting,
[5.]
McDaniel M.D., Cronenwett J.L..
Basic data related to the natural history of intermittent claudication.
Ann Vasc Surg, 3 (1989), pp. 273-277
[6.]
Gray B., Olin J..
Limitations of percutaneous transluminal angioplasty with stenting for femoropopliteal arterial occlusive disease.
Semin Vasc Surg, 10 (1997), pp. 8-16
[7.]
Becker G.J..
Limitations of peripheral angioplasty and the role of new devices.
Vascular surgery, pp. 379-390
[8.]
Dormandy J.A., Rutherford R.B..
Management of peripheral arterial disease. TASC document.
J Vasc Surg, 31 (2000), pp. S104-S229
[9.]
Rutherford R.B..
Standards for evaluating results of interventional therapy for peripheral vascular disease.
Circulation, 83 (1991), pp. 16-21
[10.]
Ahn S.S., Rutherford R.B., Becker G.J., Comerata A.J., Johnston K.W., Mc Clean G.K., et al.
Reporting standards for lower extremity arterial endovascular procedures.
J Vasc Surg, 17 (1993), pp. 1103-1107
[11.]
Rutherford R.B., Flanigan D.P., Gupta S.K., Johnston K.W., Karmody A., Whittemore A.D., et al.
Suggested standards for reports dealing with lower extremity ischemia.
J Vasc Surg, 4 (1986), pp. 80-94
[12.]
Vroegindeweij D., Vos L., Tielbeek A., Buth J., Bosch H..
Ballon angioplasty combined withprimary stenting versus ballon angioplastyalone in femoropopliteal obstructions: a comparative randomized study.
Cardiovasc Intervent Radiol, 20 (1997), pp. 420-425
[13.]
Strecker E., Boos I., Góttmann D..
Femoropopliteal artery stent placement: evaluation oflongterm success.
Radiology, 205 (1997), pp. 375-383
[14.]
Zollikofer C., Antonucci F., Pfyffer M., Redha F., Salomonowithz E., Stuckmann G., et al.
Arterial stent placement with use of the Wallstent: midterm results of clinical experience.
Radiology, 179 (1991), pp. 449-456
[15.]
Sapoval M., Long A., Raynaud A., Beysson B., Fiessinger J., Gauz J., et al.
Femoropoplitealstent placement: long-term results.
Radiology, 184 (1992), pp. 833-839
[16.]
White G., Liew S., Waugh R., Stephen M., Harris J., Kidd J., et al.
Early outcome and intermediate follow-up of vascular stents in the femoral and popliteal arteries without long-term anticoagulation.
J Vasc Surg, 21 (1995), pp. 270-279
[17.]
Rousseau H., Raillat C., Joffre F., Knight C., Ginetest M..
Treatment of femoropopliteal stenoses by means of self-expandable endoprostheses: midterm results.
Radiology, 172 (1989), pp. 961-964
[18.]
Do-dai-Do, Triller J., Walpth B., Stirnemann P., Mahler F..
A comparison study of self-expandable stents vs ballon angioplasty alone in femoropopliteal artery occlusions.
Cardiovasc Interv Radiol, 15 (1992), pp. 306-312
[19.]
Martin E.C., Katzen B.T., Benenati J.F., Diethrich E., Dorros G., Graor R., et al.
Multicenter trial of the Wallstent in the iliac and femoral arteries.
J Vasc Interv Radiol, 6 (1995), pp. 843-849
[20.]
Henry M., Amor M., Ethevenot G., Henry I., Amicabile C., Beron R., et al.
Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4 years follow-up.
Radiology, 197 (1995), pp. 167-174
[21.]
Cejna M., Thurnher S., Illiasch H., Horvath W., Waldenberger P., Hornik K., et al.
PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomised study.
J Vasc Interv Radiol, 12 (2001), pp. 23-31
[22.]
Zdanowski Z., Albrechtsson U., Lundin A., Jonung T., Ribbe E., Thorne J., et al.
Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomised controlled study.
Int Angiol, 18 (1999), pp. 251-255
[23.]
Muradin G., Bosch J., Stijnen T., Hunink M..
Ballon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis.
Radiology, 221 (2001), pp. 137-145
[24.]
Krepel V.M., Van Andel G.J., Van Erp W.F., Breslan P.J..
Percutaneous transluminal angioplasty of the femoropopliteal artery: initial and long-term results.
Radiology, 156 (1985), pp. 325-328
[25.]
Hunink M.G., Wong J.B., Donaldson M.C., Meyerovitz M.F., Harrington D.P..
Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease.
Med Decis Making, 14 (1994), pp. 71-81
[26.]
Johnston K.W..
Femoral and popliteal arteries:reanalysis of results of angioplasty.
Radiology, 183 (1992), pp. 767-771
[27.]
Henry M., Klonaris C., Amor M., Henry I., Tzvetanov K..
Which stent for which lesion in peripheral interventions?.
Texas Heart Inst J, 27 (2000), pp. 119-126
[28.]
Becquemin J., Favre J., Marzelle J., Nemoz C.H., Corsin C., Leizorovich A..
Systematic versus selective stent placement after superficial femoral artery ballon angioplasty: a multicenter prospective randomised study.
J Vasc Surg, 37 (2003), pp. 487-494
[29.]
Gray B.H., Sullivan T.M., Childs M.B., Young J.R., Olin J.W..
High incidence of restenosis/ occlusion of stents in the percutaneous treatment of long segment superficial femoral artery disease after suboptimal angioplasty.
J Vasc Surg, 25 (1997), pp. 74-83
[30.]
Liermann D., Strecker E.P., Peters J..
TheStrecker stent: indications and results in iliacand femoropopliteal arteries.
Cardiovasc Intervent Radiol, 15 (1992), pp. 298-305
[31.]
Acín F., Utrilla F., López-Quintana A., Fernández-Heredero A., March J.R..
Stents en el sector femoropoplíteo.
Angiología, 55 (2003), pp. S153-S165
[32.]
Vogel T., Shindelman L., Nackman G., Graham A..
Efficacious use of nitinol stents in the femoral and popliteal arteries.
J Vasc Surg, 38 (2003), pp. 1178-1183
Copyright © 2004. SEACV
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos